- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Government Shutdown Strains Patients, Providers
As the nation faced Day 1 of the government shutdown, federal lawmakers made no progress on funding government operations in the new fiscal year, and healthcare leaders pondered the effects of the budget impasse on patients, providers, researchers and public health programs.
As the nation faced Day 1 of the government shutdown, federal lawmakers made no progress on funding government operations in the new fiscal year, and healthcare leaders pondered the effects of the budget impasse on patients, providers, researchers and public health programs.
By Tuesday afternoon, Senate Democrats rejected the latest bill from House Republicans, who Monday night had sent back to the Senate a spending bill that would delay the healthcare reform law's individual mandate and eliminate the federal government's health benefit contribution for members of Congress, their staff and political appointees. The House bill came with a request for the two chambers to hammer out their differences in conference committee. House members resumed session on Tuesday morning, but had not acted after the Senate lobbed the ball in their court.
The House still could pass the Senate's “clean” continuing resolution, which would then move to the president for his signature and restart government operations. If House members choose to amend the Senate-passed bill again, it would still require Senate consideration.
Read the full story here: http://bit.ly/16GkV1I
Source: Modern Healthcare
Semaglutide Shows Promise for MASH Resolution, Severe Fibrosis: Naim Alkhouri, MD
May 9th 2025Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment landscape for patients with metabolic dysfunction-associated steatohepatitis (MASH) and severe fibrosis.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
